Biokart India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
- Revenue Growth 209.41%
- Profit Growth 95.91%
- Ebitda 268.53%
- Net Worth 76.12%
- Total Assets 45.17%
About Biokart India
Biokart India Private Limited (BIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 December 2011 and has a history of 13 years and one month. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Madavan Vasudevan, Hitesh Madan, and Vikram Subramanian serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900KA2011PTC061787
-
Company No.
061787
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Dec 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Biokart India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madavan Vasudevan
|
Director | 22-Dec-2011 | Current |
|
Hitesh Madan
|
Director | 22-Dec-2011 | Current |
|
Vikram Subramanian
|
Director | 22-Dec-2011 | Current |
Financial Performance of Biokart India.
Biokart India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 209.41% increase. The company also saw a substantial improvement in profitability, with a 95.91% increase in profit. The company's net worth Soared by an impressive increase of 76.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biokart India?
Unlock access to Biokart India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Genemine Discoveries Private LimitedVikram Subramanian is a mutual person
-
Theomics International Private LimitedMadavan Vasudevan is a mutual person
-
4Basecare Genomics Private LimitedHitesh Madan is a mutual person
-
4Basecare Onco Solutions Private Limited
Hitesh Madan is a mutual person
-
4Basecare Precision Health Private Limited
Hitesh Madan is a mutual person
-
Mendelian Health Technologies Private LimitedVikram Subramanian is a mutual person
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Mysore : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jul 2013 | State Bank Of Mysore | ₹0.50 M | Open |
How Many Employees Work at Biokart India?
Unlock and access historical data on people associated with Biokart India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biokart India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biokart India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
